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Abstract. Gastric cancer is a disease in which the main treatment is
surgical extirpation. The modifications introduced in the surgical treat-
ment over the last decades were accompanied by a clear increase of
survival, which reaches global values of 61% at 5 years in Japan. One of
the reasons that contribute to this improvement is early diagnosis of the
lesions. In the period between January 1, 1990 and December 31, 1999 662
patients with gastric adenocarcinoma were treated in the Service of
Surgery 1 of our hospital; 110 were refused surgical treatment. Of the
resected patients, 91 (21.4%) were classified as early gastric cancer ac-
cording to the definition of the Japanese Society of Digestive Endoscopy.
There were 30 women and 61 men, with a median age of 60.2  15 years;
3 patients had a preoperative diagnosis of gastric ulcer; 2 others were
operated without recent histology; and 1 patient was urgently resected for
a bleeding ulcer. In all the remaining patients biopsy confirmed the
presence of cancer (89%) or serious dysplasia (4.6%). The lesions had
been distributed essentially in the medium 1/3 (48.3%) and distal 1/3 of
the stomach.
Subtotal gastrectomy was accomplished in 48 patients, total gastrec-
tomy in 40, total desgastrogastrectomy in 3, and in 9 patients the surgery
involved the spleen (8 patients) and the spleen and tail of the pancreas in
1 patient. Lymphadenectomy was not performed in 5 patients, lymph
nodes by the first lymph node barrier were removed in 25 patients and by
the second barrier in 61 patients (67%). Median tumor size was 26  1.8
mm. The lesion reached the mucosa in 46 patients and the mucosa and
submucosa in 45. In 6 patients the removed lymph nodes were microscop-
ically invaded (6.7%). Five patients died (5.7%). The median follow-up of
the patients is 41  26 months; 7 patients died (8.1%) during this period;
4 died unequivocally of disease progression. The median survival of
patients was 85% at 5 years and 80% at 10 years. In our series, survival
was affected by the presence of invaded lymph nodes, not by the penetra-
tion in depth of the lesion or the size of the tumor.
Modifications in the surgical treatment of gastric cancer intro-
duced in the last decades brought a clear increase of 5-year
survival. This effect became particularly visible in Japan, whose
surgeons present survival rates at 5 years of 61% in comparison to
Western authors, whose results are approximately 40%, consider-
ing only radical surgery [1, 2]. One of the reasons that also
contribute to this survival increase is early diagnosis, which allows
the detection of more carcinomas in initial phases. In Japan this
subgroup constitutes 50%–55% of all operated patients, being a
common clinical entity, but the same does not happen in Europe
[3] and in the United States [4], where the frequency of early
diagnosis does not surpass 15%.
The classic definition of early gastric cancer, as established in
1962 (gastric adenocarcinoma confined to the mucosa or submu-
cosa, independently of the presence of lymph node invasion),
includes different stages of the disease under the same name, in
view of which, theoretically, disease prognosis by stage should be
different. An accurate staging of the disease is influenced by the
extension of the lymphadenectomy performed, since it is known
that lymph node involvement, even in the lymph node belonging
to the second barrier, is not rare and is a determinant factor of the
final prognosis.
The present study was conceived to determine incidence, pre-
sentation form and diagnostic methods, treatment, and long-term
survival of a consecutive series of patients with early gastric cancer
treated in our hospital during the last 10 years.
Materials and Methods
Between January 1, 1990 and December 31, 1999 we treated, in
Surgery 1 Service of Hospital Geral de Santo António, 662 pa-
tients with gastric adenocarcinoma. All the data from patients
with gastric adenocarcinoma, operated or not, were prospectively
registered in a specific computerized database on a personal
computer. Follow-up data of all patients were obtained in fol-
low-up consultation. Recurrences and probable cause of death
were included only after direct contact with the patient or a
member of the family.
All patients were followed every 3 months during the first 2
years of disease, and every 6 months between the 2nd and the 5th
years. Starting from the 5th year, routine surveillance became
annual. All the data obtained in consultation are reviewed
monthly and registered. The data not obtained in consultation,
relative to some patients treated in other institutions or deceased
out of the hospital, are registered from an interview with a direct
kinsman of the patients or from the data supplied by the other
institution.
Complication and surgical mortality rates were studied by chi-
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square test and Fisher’s exact test. The survival was calculated
through the method of Kaplan-Meier. For the comparison of the
curves of obtained survival, we used the log-rank test; the level of
considered significance was p  0.05.
Results
Presentation
One hundred ten patients (16.7%) were refused surgical treat-
ment; the main reasons for this decision were the presence of
disseminated disease at the time of the diagnosis and the lack of
operability conditions because of very advanced age or of impor-
tant biological limitations.
Five hundred fifty-two patients were submitted to laparotomy.
Resection was possible in 425 patients (64% of all observed
cases). Of this group, 91 cases (21.4%) are included in the defi-
nition of early gastric carcinoma, as established by the criteria of
the Japanese Society of Investigation of Gastric Cancer [5]. The
group comprised 30 women and 61 men, with a median age 
S. D. of 60.2  15 years. The youngest patient was 25 years old
and the oldest was 85. Twenty-two patients were older than 70
years and 6 older than 80 years.
The main complaints were epigastric pain (50%) and dyspeptic
syndrome (34%). Three patients were admitted with upper gas-
trointestinal bleeding for gastric ulcers, 8 patients were diagnosed
in routine endoscopy for vomiting, and 3 were operated for gastric
ulcers. Forty-four patients had symptoms for less than 6 months,
24 for less than a year, and 23 patients had complaints for more
than 12 months. Five patients had lost more than 10% of their
body weight when admitted to hospital.
Diagnosis
All patients had upper gastrointestinal endoscopy. Three patients
were admitted after an episode of upper gastrointestinal bleeding
for gastric ulcer. Other imaging methods for staging included
computed tomography (CT) scan (55%) upper gastrointestinal
barium examination (43%), and endoscopic ultrasonography
(2.2%).
Preoperative histology of adenocarcinoma was obtained in 81
(89%) patients. In 4 (4.6%) the diagnosis was high grade dyspla-
sia/in situ carcinoma. Three patients were operated without pre-
operative recent biopsies (one urgently resected due to bleeding
gastric ulcer); 3 others had gastric ulcers that did not respond to
medical treatment. The biopsies did not give malignancy indica-
tions.
Surgical Treatment
Distribution of the lesions in the stomach is shown in Figure 1.
The operations performed were dictated essentially by endoscopic
location of the lesion and by the general condition of the patient.
In relation to the stomach, subtotal gastrectomy was accomplished
in 48 patients (52.7%), total gastrectomy in 40 (43.9%), and total
desgastrogastrectomy in 3 patients (3.2%) with cancer in the
gastric stump. Surgery involved the spleen in 8 patients (8.8%)
and the spleen and tail of the pancreas in 1 patient (1.1%).
Lymphadenectomy was not performed in 5 patients, lymph
nodes of the first barrier (perigastric lymph nodes) were removed
in 25 cases (38.4%), mainly because of advanced age and related
comorbidities; lymph nodes of the second barrier were removed in
61 patients (67%).
Complications
The most frequent complications observed were cardiopulmo-
nary, affecting about 25% of the patients of the series. Complica-
tions directly related to surgery are listed in Table 1. Complication
rate showed no statistical significance when studied by chi-square
test and Fisher’s exact test.
Operative mortality rate observed at day 30 was 5.7% (5 pa-
tients). Three died of surgical complications, 1 of acute myocar-
dial infarction, and 1 of pulmonary infection. Three patients died
after total gastrectomy (7.5%) and 2 after subtotal gastrectomy
(4.2%). These numbers also did not reveal statistical significance.
Pathology
Most lesions were located in the body and antrum of the stomach.
In 2 patients (2.2%) the existence of multicentric tumors was
verified. The size of the lesions oscillated between a minimum of
3 mm and a maximum of 105 mm, with an average of 26  1.8
mm. The penetration of the lesions in depth, in the gastric wall,
reached the mucosa in 46 patients (5 in situ carcinomas–5.5%)
and the mucosa and submucosa in 45 patients (49.5%). The
average number of lymph nodes was 13 by surgical specimen
(range 0–47). Six patients had lymph node involvement (6.7%): in
4 the carcinoma invaded the mucosa and in 2 the mucosa and
submucosal layer.
The majority of patients (89.1%) were in stage Ia of the clas-
sification pTNM. The final stages of all patients are shown in
Table 2.
Follow-up
Median follow-up  S.D. of the patients was 41  26 months
(range 3–110). Eighty-one patients are alive and free from dis-
ease.
Seven patients died in this period (8.1%), 2 without evidence of
Fig. 1. Topographic distribution of lesions in the stomach.
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disease and 1 of unknown cause. Four patients died unequivocally
of progression of the disease: 2 by hepatic metastasis (at month 20
and 27), 1 for peritoneal carcinosis (at month 65), and 1 for
disseminated disease with bone and soft tissue metastasis (at
month 20). The crude survival of the series, including the opera-
tive mortality, was 85% at 5 years and 80% at 10 years. Statistical
analysis demonstrated that there is no valid statistical relationship
between survival and the parietal penetration of the tumor in the
mucosa or mucosa and submucosa (p  0.67) or its superficial
extension in the gastric epithelium (p  0.38) when we analyzed
tumors of less than 2 cm and tumors of 2–4 cm. Patient survival
was clearly affected (p  0.001) by the presence of invaded lymph
nodes in the surgical specimen.
Discussion
It is accepted by most authors that improvement of prognosis of
gastric cancer is only possible if the diagnosis is made in early
phases of the disease, which happens in Japan and other coun-
tries. An early diagnosis obtained with the wide and liberal use of
endoscopy brings about the detection of larger number of early
cancers, whose percentage can reach 17% to 27% of the total of
the detected lesions [6, 7]. This number, elevated when Western
countries are considered, is still substantially inferior to the num-
bers in the Japanese literature, in which about 50% of the patients
operated have lesions confined to the mucosa and submucosa [8].
The rate of 21.7% in our series must, for this reason, be observed
with caution, since our hospital is considered as a referral center
for gastric surgery and the number is reported in relation to the
total number of resected patients.
The distribution of the lesions by sex follows the pattern ob-
served in another published series [9–11] being more frequently
observed in men. The average age of patients is 3 years less than
the median age of all our patients with gastric cancer (62.8 years),
but age is clearly greater than the median age published in the
Japanese series [12–14]. This fact is particularly important when
we consider morbidity and mortality. Also important in our series
is the fact that the majority of our patients are in the 7th and 8th
decades of life.
All patients had, before surgery, at least one endoscopy; malig-
nant disease was diagnosed by biopsy in 89%. One patient was
urgently operated due to bleeding gastric ulcer, and 2 were oper-
ated without recent histology in the context of benign disease,
after an episode of bleeding. In 3 patients we performed surgery
for gastric ulcer and cancer was a microscopic diagnosis.
In the staging of the remaining patients, diagnosis methodology
was guided essentially for the elimination of distant metastasis by
CT scan or abdominal ultrasonography; we did not have access to
endoscopic ultrasonography in the referred period.
Surgical treatment followed the same guidelines that we use in
gastric cancer surgery: resection with proximal safety margin of
7–8 cm with lymphadenectomy for the second barrier lymph
nodes, just as defined by the Japanese authors. The topography of
the lesion, patient’s age, and associated illness conditioned the
extension of gastric resection, as well as lymphadenectomy in
some cases. Multicentricity of the tumor, which can reach a
prevalence of 9% [15] or higher, has been used as argument, in
some series, for total gastrectomy. The incidence of synchronous
lesions in our series was 2 patients (2.2%), and they were found in
the operative specimen, after total gastrectomy; on the other
hand, careful follow-up of the patients with subtotal resections
through endoscopy did not demonstrate the appearance of meta-
chronous tumors in the remaining gastric stump.
No patients had microscopic invasion of the resection margin.
Although it is debatable which margin is necessary in the treat-
ment of early lesions, we argued for margins of 7–8 cm because of
the intraoperative difficulty of location of the lesion by the sur-
geon (because it cannot be palpated), our lack of previous knowl-
edge in relation to the lesion’s parietal penetration, and the
possibility of the lesion’s proximal microscopic extension [16].
Incidence of lymph node metastasis in early cancer reaches
different values in the literature, being usually greater than 10%
[12, 17]. Extension of lymphadenectomy in these lesions is a
controversial issue, the Western school, generally speaking, more
conservative and adept at limited resection (first lymph node
barrier-D1), and the Japanese school adept at more aggressive
resection usually for second lymph node barrier (D2 type). On the
other hand, the relationship is known between transmural inva-
sion and the rate of positive lymph nodes: 0%–11% for mucosa
invasion and 2%–29% for the mucosa and submucosa [12, 17, 18].
Knowing that the presence of positive lymph nodes is a main
determinant of gastric cancer prognosis and having not observed,
Table 1. Surgical complications related to procedure.
Intraabdominal
leaks
Intraabdominal
abscesses Peritonitis
Acute
pancreatitis
Anastomosis
stricture Mortality
Subtotal gastrectomy (n  48) 1a 2b 1 2c 4.2%
Total gastrectomy (n  40) 1b,d 5 1e 7.5%
Total desgastrogastrectomy (n  3) 1 0%
Total (n  91) 2 (2.2%) 8 (8.8%) 1 (1.1%) 1 (1.1%) 2 (2.2%) 5.7%
aDuodenal stump leakage.
bEsophagojejunal leakage: patient died of intraabdominal sepsis.
cLate complications: dilatation of the stricture was the only procedure.
dPatient died of intraabdominal sepsis.
ePatient died of multiorgan failure.
Table 2. Pathologic staging (pTNM) classification of the 91 patients.
T N M Stage Patients %
Is 0 0 0 4 4.3
Is 1 0 IB 1 1.1
1 0 0 IA 81 89.1
1 1 0 IB 3 3.3
1 2 0 II 2 2.2
Is: in situ carcinoma.
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in our patients, an increase of mortality related to second barrier
lymphadenectomy (results not published), we think we should
keep the same type of lymph node resection used for all gastric
cancers.
Lymphadenectomy by the second barrier was performed in
67% of the patients. Six patients had positive lymph nodes (6.7%).
In 4 the lesion just reached the mucosa and in the remaining ones
the mucosa and submucosa. In 5 of these patients a D-2 type
lymphadenectomy was used, and 2 patients had positive lymph
nodes in the common hepatic artery group. In 5 of these patients
the relation between invaded/resected lymph nodes is greater than
0.2, which constitutes a bad prognostic factor [19]. The factors
mentioned above corroborate our position in favor of a wide
lymph node clearance, which whenever possible should be of the
D-2 type; some Japanese authors believe that this practice can
have a beneficial effect in the survival of patients with tumors
reaching the submucosa [20, 21].
The main morbidity of our patients involved cardiopulmonary
problems (25% of the patients, unpublished results), which are
essentially attributable to the advanced age of the group. In
relation to surgical complications the most prevalent was intraab-
dominal fluid collection (8.8%), sometimes secondarily infected,
which led to surgical or ultrasonography-oriented drainage. The
mortality observed (5.7%) was due to the evolution of preestab-
lished diseases in 2 cases and in 3 of complications directly related
to the surgery performed; these patients were in their 7th, 8th, and
9th decades of life. An analysis of the type of operation performed
(total gastrectomy/subtotal gastrectomy) did not demonstrate dif-
ferences in mortality between the two operations.
No adjuvant therapy was performed in patients that survived
the surgery, whether or not there were invaded lymph nodes or
parietal invasion of the tumor.
Our experience does not include endoscopic mucosectomy,
endoscopic laser ablation, or atypical gastric resection by video-
laparoscopy. The first technique provides extremely trustworthy
diagnosis before surgery, which was not possible in our hospital
for lack of technical means (endoscopic ultrasonography). This
technique became available starting in January 2000. For the same
reason we were previously unable to provide mini-invasive sur-
gery, but we can now use it in patients of high surgical risk, with
lesions of small metastatic potential and in certain locations where
the extirpation of the entire gastric wall is contemplated [27].
Destroying the tumor by laser has the problem of not providing
tissue for the pathologist, which makes the method a palliative
one.
Crude survival of our patients, 85% at 5 years, 80% at 10 years,
is inferior to the 90%–100% survival mentioned by Japanese
authors [12, 13, 17, 22], but it is comparable to values of 70%–90%
at 5 years and 60%–80% at 10 years presented by Western
authors [16, 23, 24]. We think that the differences may be caused
by a larger surgical mortality in the Western world because of
older patients with a smaller performance index. Once statistical
correction of these factors is made, we think that, considering the
same type of resection and lymphadenectomy, differences among
Japanese and Western series will greatly diminish.
Routine follow-up of these patients includes once-a-year en-
doscopy in cases of subtotal resection, and radiologic (CT, US)
and other investigations adapted to the complaints or the clinical
picture of the patient. Synchronous or metachronic neoplasias, in
the gastric stump or in other organs, are frequently mentioned in
the literature [16, 25, 26] and could be responsible for a high
mortality rate in the follow-up of the patients [26]. They manifest
as Hodgkin disease, leiomiosarcoma, cancer of the endometrium,
colon, and neoplasias, and they are, in our opinion, the main
reason for careful surveillance of these patients, although we have
not found any metachronic tumor in follow-up of our patients.
Résumé. Le traitement du cancer de l’estomac est l’ablation chirurgicale.
Les modifications introduites ces dernières décennies sont accompagnées
d’une nette amélioration de la survie, ayant atteint globalement 61% à 5
ans au japon. Une des raisons de l’amélioration est le diagnostic plus
précoce des lésions. Pendant la période entre le 1 jan 1990 et le 31 dec
1999, nous avons traité 662 patients porteurs d’adénocarcinome gastrique
dans le service de Chirurgie I de notre hôpital; 110 n’ont pas eu de
traitement chirurgical. Parmi les patients ayant eu une résection, 91
(21.4%) ont été classés comme porteurs de cancer gastrique au début
selon la classification de la Société japonaise de l’endoscopie digestive. Il
y avait 30 femmes et 61 hommes, d’un âge moyen de 60.2  15 ans. Le
diagnostic préopératoire a été un ulcère gastrique chez trois patients,
deux autres patients ont été opérés sans histologie récente et un patient
a été opéré en urgence pour ulcère hémorragique. Chez tous les autres
patients, la biopsie a confirmé la présence de cancer (89%) ou de
dysplasie sévère (4.6%). Les lésions ont intéressé essentiellement le tiers
moyen (48.3%) et distal de l’estomac. Une gastrectomie subtotale a été
réalisée chez 48 patients, une gastrectomie totale chez 40, une
dégastrogastrectomie totale chez trois et chez neuf patients, on a réalisé
une splénectomie (8 patients) ou une splénopancréatectomie caudale (1
patient). Aucune lymphadénectomie n’a été réalisée chez cinq patients, 25
ont eu une lymphadénectomie D1 alors que 61 ont eu une
lymphadénectomie D2 (67%). La taille moyenne de la tumeur a été de 26
 1.8 mm. La lésion a atteint la muqueuse chez 46 patients et la
sous-muqueuse chez 45. Chez six patients, les ganglions enlevés étaient
envahis microscopiquement (6.7%). La mortalité a été de cinq (5.7%)
patients. La médiane de suivi des patients a été de 41 26 mois, avec sept
(8.1%) patients décédés pendant cette période: quatre de façon
non-équivoque de leur maladie. La médiane de survie des patients a été de
85% à 5 ans et de 80% à 10 ans. Dans notre série, la survie a été affectée
par la présence de ganglions lymphatiques envahis, sans rapport avec la
profondeur ou la taille de la lésion.
Resumen. El cáncer gástrico es una entidad nosológica cuyo tratamiento
es fundamentalmente quirúrgico. Las modificaciones, realizadas durante
las pasadas décadas, a las técnicas exeréticas del cáncer gástrico han
dado origen a un incremento evidente de la supervivencia, que en Japón
alcanza hasta el 61% a los 5 años. Una de las causas determinantes de
esta mayor supervivencia es el diagnóstico precoz de las lesiones
cancerosas. En el Servicio de Cirugía I de nuestro hospital, se trataron
entre 01/01/1990 y el 31/12/1999, 662 pacientes con adenocarcinoma
gástrico; en 110 pacientes el tratamiento quirúrgico no se consideró
indicado. De los pacientes sometidos a resección gástrica, 91 (21.4%)
fueron diagnosticados de acuerdo, con la clasificación y definición de la
Sociedad Japonesa de Endoscopia Digestiva, como cáncer gástrico precoz.
Se trataba de 30 mujeres y 61 varones cuya edad media fue de 60.2  15
años; de todos ellos, 3 fueron diagnosticados antes de la intervención
como portadores de una úlcera gástrica y otros dos, fueron intervenidos
de urgencia, sin estudio anatomopatológico reciente, por presentar un
estómago sangrante. En los restantes pacientes la biopsia confirmó en el
89% de los casos la existencia de un cáncer o de grave displasia (4.6%).
Las lesiones cancerosas se localizaban sobre todo en el 1/3 medio (48.3%)
y 1/3 distal del estómago. En 48 enfermos se realizó una gastrectomía
subtotal, en 40 una gastrectomía total, en 3 una desgastrogastrectomía
total; en 8 pacientes la resección gástrica se acompañó de una
esplenectomía y en 1 de esplenectomía y resección de la cola del páncreas.
En 5 pacientes no se realizó linfadenectomía alguna, en 25 la
linfadenectomía se limitó a la 1a barrera linfática y en 61 se extendió
hasta la 2a barrera linfática (67%). El tamaño promedio del cáncer fue de
26  1.8 mm. En 46 casos la tumoración afectaba exclusivamente a la
mucosa, mientras que en 45 pacientes estaban afectadas la mucosa y
submucosa gástricas. Sólo en 6 pacientes se constató invasión tumoral de
los ganglios linfáticos extirpados (6.7%). La mortalidad fue del 5.7% (5
casos). El seguimiento medio alcanzó los 41  26 meses registrándose
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durante este periodo 7 fallecimientos (8.1%) de los que 4 se debieron, sin
duda alguna, a la progresión del cáncer. La supervivencia media a los 5
años fue del 85% y a los 10 del 80%. En nuestra serie, la supervivencia
guarda estrecha relación con la invasión metastásica de ganglios
linfáticos y no con el crecimiento en profundidad del tumor, ni con el
tamaño del mismo.
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